These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for Kim EH; Siegel BA; Teoh EJ; Andriole GL; Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848 [TBL] [Abstract][Full Text] [Related]
15. Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer. Bitar R; Martiniova L; Bell D; Ravizzini G Clin Nucl Med; 2020 Apr; 45(4):e208-e210. PubMed ID: 31977491 [TBL] [Abstract][Full Text] [Related]
16. Small Lymph Node Metastasis Detected by 68Ga-Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low-Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer. Chaussé G; Abikhzer G; Probst S Clin Nucl Med; 2018 Apr; 43(4):250-251. PubMed ID: 29465489 [TBL] [Abstract][Full Text] [Related]
18. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766 [TBL] [Abstract][Full Text] [Related]
19. The Clinical Utility of Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial. Andriole GL; Kostakoglu L; Chau A; Duan F; Mahmood U; Mankoff DA; Schuster DM; Siegel BA; J Urol; 2019 Feb; 201(2):322-331. PubMed ID: 30179618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]